Yaskawa Solectria Solar, a wholly owned subsidiary of Yaskawa America, Inc., is the largest U.S.-based inverter manufacturer, with design and engineering offices in Lawrence, MA, and world-class production facilities in Buffalo Grove, IL and Franklin, WI. Backed by Yaskawa, a global leader in motor drives and robotics with over a century of expertise in power electronics and inverters, Yaskawa Solectria Solar remains committed to delivering the highest-quality solar inverters and driving innovation in the industry. Yaskawa Solectria Solar has over 20 years of experience and the company’s flagship product line, the Solectria® XGI 1500 inverters, reflects this commitment to quality and innovation. Proud to say, our inverters are made in the USA. Visit for more information www.solectria.com | Yaskawa Solectria Solar, a wholly owned subsidiary of Yaskawa America, Inc., is the largest U.S.-based inverter manufacturer, with design and engineering offices in Lawrence, MA, and world-class production facilities in Buffalo Grove, IL and Franklin, WI. With over 22 years of experience Yaskawa Solectria Solar is the only PV inverter designed, made, and serviced in the USA. The company’s flagship American-made product line, the Solectria® XGI 1500 inverters, along with the XGI 1500-1MW Series Inverters, a full lineup of string combiners designed for the XGI inverters, 1-2MW factory-integrated Power Racks, and DC-coupled and AC-coupled storage solutions complete the product family. With this full product solution offering Yaskawa Solectria Solar remains committed to delivering the highest-quality solar inverters and driving innovation in the industry.
Yankee Hill Machine Co.
Silencers and accessories
Xylem + Evoqua
Evoqua has joined Xylem to solve global water challenges. For pharma, we deliver high-purity water solutions—Purified, WFI, lab, utility, and wastewater. Our upgraded MemGEN™ system paired with our Sophis™ Digital platform and world-class service network will optimize uptime, performance, and compliance through smart tech, analytics, and expert support in the manufacturing space.
XtalPi
Established in 2014, XtalPi’s founders recognized a common hurdle in drug development in the space of solid polymorphism, which they successfully tackled with quantum physics predictions. Since then, XtalPi has maintained its focus on identifying and then attacking traditional bottlenecks in drug discovery by developing novel and disruptive technologies. Through considerable capital investments in automation and personnel, XtalPi now employs approximately 1000 individuals worldwide. Our expert team, located in our four geographic centers of excellence, has culminated in XtalPi successfully engaging in collaborative research with nearly all the top-20 pharmaceutical companies in the world. | XtalPi is an innovative technology company powered by artificial intelligence (AI) and robotics. Founded in 2015 on the MIT campus, XtalPi is dedicated to driving intelligent and digital transformation in the life science and new materials industries. With tightly interwoven quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of technology solutions, services, and products to accelerate and empower innovation for biopharmaceutical and new materials companies worldwide. | XtalPi is a global technology platform company powered by artificial intelligence (AI) and robotics. Founded in 2015, XtalPi is dedicated to driving intelligent and digital transformation in life sciences and discovering better therapeutics and new materials. By integrating and synergizing quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of innovative solutions, services, and products to empower our partners in the biopharmaceutical, chemical, new energy, and new materials sectors worldwide.
XENON Corporation
XENON is the world leader in Pulsed Light technology for a wide vareity of food safety, industrial, medical and research applications. With 60 years of experience in Pulsed ight technology, XENON has thousands of systems operating in research laboratories and production lines around the world. For more information, visit www.xenoncorp.com.
Xellar Biosystems
Xellar Biosystems is a Wet Artificial Intelligence (AI) biotechnology company, combining machine learning and AI with large-scale wet-lab experiments, tackling the most challenging problem in modern drug discovery – harnessing the complexity of human biology to accelerate drug discovery and development.
WuXi AppTec
WuXi AppTec offers a comprehensive platform of targeted oncology models and translational services to support cancer drug development teams within the global pharmaceutical and healthcare industry. Our services include CAR-T cell therapy, antibody-drug conjugates, CRISPR-mediated target validation, drug-resistant CDX/PDX tumor models, and discovery/clinical biomarker services. | As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, and cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received AA ESG rating from MSCI in 2022 and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that “every drug can be made and every disease can be treated.”
WS Development
Massachusetts-based WS Development is a mixed-use developer with a singular mission: creating places people want to be. With an approach that values art, science, innovation and, above all else, people, WS strives to engage each community it serves with best-in-class experiences, designed with our customers, tenants and partners in mind. Established in 1990, WS is one of few vertically-integrated real estate companies that conceptualizes, owns, operates and leases more than 100 properties that range from cutting-edge urban spaces to lifestyle and community centers. With over 22 million square feet of existing space and an additional nine million square feet under development, it is one of the largest privately-owned development firms in the country. For more information, visit www.wsdevelopment.com, call 617.232.8900 or follow WS Development on LinkedIn.